Guardian Pharmacy Stock Forward View - Double Exponential Smoothing
| GRDN Stock | 32.87 1.43 4.55% |
Guardian Stock outlook is based on your current time horizon.
As of today the value of rsi of Guardian Pharmacy's share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Guardian Pharmacy hype-based prediction, you can estimate the value of Guardian Pharmacy Services from the perspective of Guardian Pharmacy response to recently generated media hype and the effects of current headlines on its competitors.
The Double Exponential Smoothing forecasted value of Guardian Pharmacy Services on the next trading day is expected to be 33.28 with a mean absolute deviation of 0.71 and the sum of the absolute errors of 42.02. Guardian Pharmacy after-hype prediction price | USD 32.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Guardian Pharmacy to cross-verify your projections. Guardian Pharmacy Additional Predictive Modules
Most predictive techniques to examine Guardian price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Guardian using various technical indicators. When you analyze Guardian charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Guardian Pharmacy Double Exponential Smoothing Price Forecast For the 7th of February
Given 90 days horizon, the Double Exponential Smoothing forecasted value of Guardian Pharmacy Services on the next trading day is expected to be 33.28 with a mean absolute deviation of 0.71, mean absolute percentage error of 0.88, and the sum of the absolute errors of 42.02.Please note that although there have been many attempts to predict Guardian Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Guardian Pharmacy's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Guardian Pharmacy Stock Forecast Pattern
| Backtest Guardian Pharmacy | Guardian Pharmacy Price Prediction | Research Analysis |
Guardian Pharmacy Forecasted Value
In the context of forecasting Guardian Pharmacy's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Guardian Pharmacy's downside and upside margins for the forecasting period are 30.54 and 36.02, respectively. We have considered Guardian Pharmacy's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Guardian Pharmacy stock data series using in forecasting. Note that when a statistical model is used to represent Guardian Pharmacy stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.0913 |
| MAD | Mean absolute deviation | 0.7123 |
| MAPE | Mean absolute percentage error | 0.0237 |
| SAE | Sum of the absolute errors | 42.0231 |
Predictive Modules for Guardian Pharmacy
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Guardian Pharmacy. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardian Pharmacy's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Guardian Pharmacy After-Hype Price Density Analysis
As far as predicting the price of Guardian Pharmacy at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Guardian Pharmacy or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Guardian Pharmacy, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Guardian Pharmacy Estimiated After-Hype Price Volatility
In the context of predicting Guardian Pharmacy's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Guardian Pharmacy's historical news coverage. Guardian Pharmacy's after-hype downside and upside margins for the prediction period are 30.11 and 35.59, respectively. We have considered Guardian Pharmacy's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Guardian Pharmacy is very steady at this time. Analysis and calculation of next after-hype price of Guardian Pharmacy is based on 3 months time horizon.
Guardian Pharmacy Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Guardian Pharmacy is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Guardian Pharmacy backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Guardian Pharmacy, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.25 | 2.74 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
32.87 | 32.85 | 0.06 |
|
Guardian Pharmacy Hype Timeline
Guardian Pharmacy is currently traded for 32.87. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Guardian is forecasted to decline in value after the next headline, with the price expected to drop to 32.85. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -0.06%, whereas the daily expected return is currently at 0.25%. The volatility of related hype on Guardian Pharmacy is about 27400.0%, with the expected price after the next announcement by competition of 32.87. About 38.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Historical Fundamental Analysis of Guardian Pharmacy to cross-verify your projections.Guardian Pharmacy Related Hype Analysis
Having access to credible news sources related to Guardian Pharmacy's direct competition is more important than ever and may enhance your ability to predict Guardian Pharmacy's future price movements. Getting to know how Guardian Pharmacy's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Guardian Pharmacy may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TXG | 10X Genomics | 0.00 | 0 per month | 2.78 | 0.03 | 7.46 | (3.91) | 17.95 | |
| PRCT | Procept Biorobotics Corp | 0.00 | 0 per month | 0.00 | (0.05) | 7.06 | (5.10) | 17.65 | |
| TWST | Twist Bioscience Corp | 0.00 | 0 per month | 2.84 | 0.18 | 7.70 | (4.95) | 16.27 | |
| NUVB | Nuvation Bio | 0.00 | 0 per month | 4.59 | 0.06 | 7.33 | (5.41) | 68.61 | |
| NHC | National HealthCare | 0.00 | 0 per month | 1.52 | 0.15 | 4.32 | (2.20) | 9.28 | |
| QDEL | Quidel | 0.00 | 0 per month | 3.25 | 0.15 | 8.12 | (4.88) | 24.38 | |
| MD | Mednax Inc | 0.00 | 0 per month | 0.00 | (0.11) | 2.95 | (3.57) | 7.73 | |
| MESO | Mesoblast | 0.00 | 0 per month | 3.26 | 0.01 | 5.49 | (4.87) | 19.08 | |
| JANX | Janux Therapeutics | 0.1 | 8 per month | 0.00 | (0.10) | 7.88 | (5.30) | 63.52 | |
| EWTX | Edgewise Therapeutics | 0.00 | 0 per month | 4.44 | 0.13 | 12.91 | (5.57) | 38.85 |
Other Forecasting Options for Guardian Pharmacy
For every potential investor in Guardian, whether a beginner or expert, Guardian Pharmacy's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Guardian Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Guardian. Basic forecasting techniques help filter out the noise by identifying Guardian Pharmacy's price trends.Guardian Pharmacy Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guardian Pharmacy stock to make a market-neutral strategy. Peer analysis of Guardian Pharmacy could also be used in its relative valuation, which is a method of valuing Guardian Pharmacy by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Guardian Pharmacy Market Strength Events
Market strength indicators help investors to evaluate how Guardian Pharmacy stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Guardian Pharmacy shares will generate the highest return on investment. By undertsting and applying Guardian Pharmacy stock market strength indicators, traders can identify Guardian Pharmacy Services entry and exit signals to maximize returns.
Guardian Pharmacy Risk Indicators
The analysis of Guardian Pharmacy's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Guardian Pharmacy's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting guardian stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.07 | |||
| Semi Deviation | 2.43 | |||
| Standard Deviation | 2.74 | |||
| Variance | 7.5 | |||
| Downside Variance | 6.58 | |||
| Semi Variance | 5.89 | |||
| Expected Short fall | (2.36) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Guardian Pharmacy
The number of cover stories for Guardian Pharmacy depends on current market conditions and Guardian Pharmacy's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Guardian Pharmacy is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Guardian Pharmacy's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Guardian Pharmacy Short Properties
Guardian Pharmacy's future price predictability will typically decrease when Guardian Pharmacy's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Guardian Pharmacy Services often depends not only on the future outlook of the potential Guardian Pharmacy's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Guardian Pharmacy's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 62 M | |
| Cash And Short Term Investments | 4.7 M |
Check out Historical Fundamental Analysis of Guardian Pharmacy to cross-verify your projections. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Will Consumer Staples Distribution & Retail sector continue expanding? Could Guardian diversify its offerings? Factors like these will boost the valuation of Guardian Pharmacy. Market participants price Guardian higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Guardian Pharmacy data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Guardian Pharmacy requires distinguishing between market price and book value, where the latter reflects Guardian's accounting equity. The concept of intrinsic value - what Guardian Pharmacy's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Guardian Pharmacy's price substantially above or below its fundamental value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Guardian Pharmacy's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.